Journal of Medicinal Chemistry | Vol 64, No 24
https://pubs.acs.org/toc/jmcmar/currentJournal of Medicinal Chemistry 2021, 64, 21, 15515-15518 (Editorial) Publication Date (Web): November 1, 2021 First Page Full text PDF Perspectives Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia Hao Lei , San-Qi Zhang , Shu Fan , Huan-Rong Bai , Hong-Yi Zhao , Shuai Mao , and Minhang Xin*
Journal of Medicinal Chemistry | Vol 64, No 22
pubs.acs.org › toc › jmcmarNov 25, 2021 · Journal of Medicinal Chemistry 2021, 64, 22, 16703-16710 (Article) Publication Date (Web): November 4, 2021. Abstract. Full text. PDF. ABSTRACT. Intracellular phosphorylation of therapeutic nucleoside analogues into their active triphosphate metabolites is a prerequisite for their pharmacological activity.
Journal of Medicinal Chemistry - Wikipedia
https://en.wikipedia.org/wiki/Journal_of_Medicinal_ChemistryThe Journal of Medicinal Chemistry is a peer-reviewed medical journal covering research in medicinal chemistry. It is published by the American Chemical Society. It was established in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry and obtained its current name in 1963. Portoghese had served as editor-in-chief from 1972-2011. In 2012, Gunda I. Georg (University of Minnesota) and Shaomeng Wang (University of Michigan) succeeded Philip S. Portoghese (Univers…
Journal of Medicinal Chemistry | Vol 64, No 24
pubs.acs.org › toc › jmcmarJournal of Medicinal Chemistry 2021, 64, 21, 15787-15798 (Article) Publication Date (Web): October 27, 2021. Abstract. Full text. PDF. ABSTRACT. Inhibition of TGFβ signaling in concert with a checkpoint blockade has been shown to provide improved and durable antitumor immune response in mouse models.